CDH5(PAC)CreERT2 Mouse

Cdh5(PAC)-CreERT2 enable efficient inducible conditional recombinase expression in embryonic and adult endothelial cells (tissue-specific loxP knockout/knockin/transgene). The Cdh5(PAC)-CreERT2 mouse is an ideal tool in the study of gene function in…

Contributors

Inventor Institute
Ralf H. Adams Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Cat. #: 151520
Target: Estrogen receptor (ERT2) under the vascular endothelial cadherin (Cdh5(PAC)) promoter.
Disease: Cancer;Cancer
Model: Conditional KO
Zygosity: Heterozygous
Phenotype: The Cdh5(PAC)-CreERT2 mouse exhibits tissue-specific expression of an inducible Cre-ERT2 fusion protein, enabling tamoxifen-induced Cre recombinase activity in vascular endothelial cells.
Product description: Cdh5(PAC)-CreERT2 enable efficient inducible conditional recombinase expression in embryonic and adult endothelial cells (tissue-specific loxP knockout/knockin/transgene). The Cdh5(PAC)-CreERT2 mouse is an ideal tool in the study of gene function in angiogenesis, atherosclerosis and neovascularisation.
Conditional: Yes
Conditional description: Conditional Cre-ERT2 expression under Cdh5(PAC) promoter in endothelial cells; inducible Cre activity by treatment with hormone (tamoxifen), inducing translocation of Cre-ERT2 to nucleus.
CRISPR: Yes
Genetic background: A Cdh5(PAC)-CreERT2 transgene vector, containing a genomic Cdh5(PAC) promoter fragment fused to a CreERT2 cDNA, was injected into fertilised embryos (C57BL/6 or FVB/N). Founder lines were back-crossed to establish mice heterozygous for the Cdh5(PAC)-CreERT2 transgene.
Production details: A Cdh5(PAC)-CreERT2 transgene vector, containing a genomic Cdh5(PAC) promoter fragment fused to a CreERT2 cDNA, was injected into fertilised embryos (C57BL/6 or FVB/N). Founder lines were back-crossed to establish mice heterozygous for the Cdh5(PAC)-CreERT2 transgene.
Additional notes: The Cdh5(PAC)-CreERT2 mouse exhibits tissue-specific expression of an inducible Cre-ERT2 fusion protein, enabling tamoxifen-induced Cre recombinase activity in vascular endothelial cells. Administration of tamoxifen induces nuclear translocation of the Cre-ERT2 fusion protein, and subsequent Cre recombinase activity, allowing knockout/knockin/transgene studies of loxP-flanked genes in vascular endothelial cells. Non-induced Cdh5(PAC)-CreERT2 mice demonstrate no Cre recombinase activity, while tamoxifen-induced Cdh5(PAC)-CreERT2 mice demonstrate high penetrance in vascular endothelial cells (95%+).
Shipping conditions: Embryo/Spermatoza- Dry Ice
References:

Machi et al. 2024. Front Cell Div Biol. 12:1-15. DoI: 10.3389/fcell.2024.1407097.

Brart et al. 2011. J Exp Med. 208(6):1267-78. PMID: 21576386.

Lipid phosphate phosphatase 3 enables efficient thymic egress.

Luna-Zurita et al. 2010. J Clin Invest. 120(10):3493-507. PMID: 20890042.

Pitulescu et al. 2010. Nat Protoc. 5(9):1518-34. PMID: 20725067.

Robson et al. 2010. Dev Dyn. 239(9):2435-42. PMID: 20652948.

Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation.

The TGF type II receptor plays a critical role in the endothelial cells during cardiac development.

Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice.

Wang et al. 2010. Nature. 465(7297):483-6. PMID: 20445537.

Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.

Mahmoud et al. 2010. Circ Res. 106(8):1425-33. PMID: 20224041.

Pathogenesis of arteriovenous malformations in the absence of endoglin.

Bazigou et al. 2009. Dev Cell. 17(2):175-86. PMID: 19686679.

Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.

Benedito et al. 2009. Cell. 137(6):1124-35. PMID: 19524514.

The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis.

Srensen et al. 2009. Blood. 113(22):5680-8. PMID: 19144989.

DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries.

Citations And Reviews

Related Tools for Mouse models

Cat. # Tool Name
151502 CyclinD1-/- KO Mouse Key Info View Tool
151474 DR3-/- KO Mouse Key Info View Tool
151481 DLL1 Floxed Mouse Key Info View Tool
151550 Integrin a6b4 Mouse Key Info View Tool
151518 Lupus Mouse Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.